| Name | Title | Contact Details |
|---|
Ensho Therapeutics, Inc. is a privately held, clinical-stage biopharmaceutical company focused on developing breakthrough oral therapies for patients with inflammatory diseases. The companys initial focus is on a pipeline of oral, selective small molecule inhibitors of lymphocyte homing integrin α4β7 for IBD, a mechanism already validated by a commercially available antibody. Enshos assets were acquired from EA Pharma Co., Ltd., a subsidiary of Eisai Co., Ltd., that is focused on gastrointestinal disease. Ensho is preparing to initiate a Phase 2 clinical program in UC with NSHO-101, the lead asset in the companys pipeline.
National Cable Communications LLC is a New York, NY-based company in the Business Services sector.
Core 6 Solutions, LLC is a San Antonio, TX-based company in the Business Services sector.
Brackit is a mobile live show where you and your friends battle in games of brackets to see who knows best. Your goal is to match the picks of the live show guest. If your picks match, you can win everything from gifts to cash prizes!